MediXall Group, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q3 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: MediXall Group, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2023.
MediXall Group, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -113 %, a 36.9% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2023	-113	+66.3	+36.9%	Sep 30, 2023
Q2 2023	-119	+167	+58.4%	Jun 30, 2023
Q1 2023	-129	+850	+86.8%	Mar 31, 2023
Q4 2022	-147	-577	-134%	Dec 31, 2022
Q3 2022	-180	-431	-171%	Sep 30, 2022
Q2 2022	-286	-442	-283%	Jun 30, 2022
Q1 2022	-979	-1.12K	-786%	Mar 31, 2022
Q4 2021	430	+256	+147%	Dec 31, 2021
Q3 2021	251	+120	+91.9%	Sep 30, 2021
Q2 2021	156	-13.7	-8.04%	Jun 30, 2021
Q1 2021	143	-50.1	-26%	Mar 31, 2021
Q4 2020	174	+57	+48.6%	Dec 31, 2020
Q3 2020	131	+48.2	+58.3%	Sep 30, 2020
Q2 2020	170			Jun 30, 2020
Q1 2020	193			Mar 31, 2020
Q4 2019	117			Dec 31, 2019
Q3 2019	82.8			Sep 30, 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.